Clinical and technical challenges of cancer reirradiation: Words of wisdom - Institut Curie Accéder directement au contenu
Article Dans Une Revue Critical Reviews in Oncology/Hematology Année : 2022

Clinical and technical challenges of cancer reirradiation: Words of wisdom

Résumé

Since the development of new radiotherapy techniques that have improved healthy tissue sparing, reirradiation (reRT) has become possible. The selection of patients eligible for reRT is complex given that it can induce severe or even fatal side effects. The first step should therefore be to assess, in the context of multidisciplinary staff meeting, the patient's physical status, the presence of sequelae resulting from the first irradiation and the best treatment option available. ReRT can be performed either curatively or palliatively to treat a cancer-related symptom that is detrimental to the patient's quality of life. The selected techniques for reRT should provide the best protection of healthy tissue. The construction of target volumes and the evaluation of constraints regarding the doses that can be used in this context have not yet been fully codified. These points raised in the literature suggest that randomized studies should be undertaken to answer pending questions.

Domaines

Cancer
Fichier principal
Vignette du fichier
Beddok_CROH2022_HAL.pdf (2.19 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

inserm-03873571 , version 1 (26-11-2022)

Identifiants

Citer

Arnaud Beddok, Valentin Calugaru, Ludovic de Marzi, Pierre Graff, Jean-Luc Dumas, et al.. Clinical and technical challenges of cancer reirradiation: Words of wisdom. Critical Reviews in Oncology/Hematology, 2022, 174, pp.103655. ⟨10.1016/j.critrevonc.2022.103655⟩. ⟨inserm-03873571⟩
62 Consultations
336 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More